Wockhardt launches midazolam injection in US
MUMBAI, Nov 14 (Reuters) - India's Wockhardt Ltd (WCKH.BO: Quote, Profile, Research) said late on Thursday it launched midazolam injection in the United States after approval of the U.S. Food and Drug Administration.
The total market in the U.S. for midazolam injections, used to treat acute insomnia and anxiety, is $56 million, Wockhardt said in a statement. (Reporting by Bharghavi Nagaraju; Editing by Harish Nambiar)
November 14, 2008